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The murine autosomal dominant cataract mutants created in mutagenesis experiments have proven to be a
powerful resource for modelling the biological processes involved in cataractogenesis. We report a mutant
which in the heterozygous state exhibits mild pulverulent cataract named ‘opaque ﬂecks in lens’, symbol Oﬂ.
By molecular mapping, followed by a candidate gene approach, the mutant was shown to be allelic with a
knockout of the bZIP transcription factor, Maf. Homozygotes for Oﬂ and for Maf null mutations are similar but
a new effect, renal tubular nephritis, was found in Oﬂ homozygotes surviving beyond 4 weeks, which may
contribute to early lethality. Sequencing identiﬁed the mutation as a G!A change, leading to the amino-acid
substitution mutation R291Q in the basic region of the DNA-binding domain. Since mice heterozygous for
knockouts of Maf show no cataracts, this suggests that the Oﬂ R291Q mutant protein has a dominant effect.
We have demonstrated that this mutation results in a selective alteration in DNA binding afﬁnities to target
oligonucleotides containing variations in the core CRE and TRE elements. This implies that arginine 291 is
important for core element binding and suggests that the mutant protein may exert a differential downstream
effect amongst its binding targets. The cataracts seen in Oﬂ heterozygotes and human MAF mutations are
similar to one another, implying that Oﬂmay be a model of human pulverulent cortical cataract. Furthermore,
when bred onto a different genetic background Oﬂ heterozygotes also show anterior segment abnormalities.
The Oﬂmutant therefore provides a valuable model system for the study of Maf, and its interacting factors, in
normal and abnormal lens and anterior segment development.
INTRODUCTION
Cataract is the commonest preventable cause of blindness
worldwide. Inherited autosomal dominant cataract represents
around half of congenital forms. Several underlying genes have
now been identified, in particular those affecting lens
membrane and crystallin genes (1). However in many families
the genetic basis remains undefined. Twin studies have recently
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shown that genetic factors account for approximately 50% of
the contribution to age-related cataract (2). While the specific
genetic contributors are not known, the genes identified in
congenital cataract—particularly those associated with pro-
gressive phenotypes—represent attractive candidates.
Mutagenesis experiments in mice have led to the production
of a large resource, with 200 murine dominant cataract
mutants generated (3). Offspring have been scored for cataracts
after parental (usually male) mutagenic treatment. Many
mutants have been mapped and the molecular basis defined,
including mutations in genes for crystallins, the lens protein
Lim2, the lens-specific gap junction protein Gja8, and the
transcription factors Pax2, and Pax6. These provide excellent
mammalian models for human cataractogenesis (3).
MAF has been identified as a human disease gene associated
with presenile cataract (4). MAF, a bZIP transcription factor, is
expressed early in the development of the lens and differentiat-
ing lens fibres, and is central to lens crystallin gene regulation
(5,6). It functions as both a homo and heterodimer and binds to
maf response elements (MAREs) (7,8). Homozygous null
mutant Maf mouse embryos have defective lens formation,
small eyes and decreased expression of crystallins (5,9,10).
Heterozygous null mice exhibit normal eye development.
We report a murine form of cataract, designated Ofl (opaque
flecks in lens), resulting from Maf mutation. The R291Q
missense mutation substitutes a conserved residue in the DNA-
binding domain of Maf. Electromobility shift assays (EMSAs)
on the mutant protein demonstrate loss of binding to variant
MARE oligonucleotides. Heterozygotes exhibit a cataract
similar in phenotype to the heterozygous R288P human MAF
mutation. When bred onto a different genetic background Ofl
heterozygotes also show anterior segment abnormalities. The
Ofl mutant therefore provides a valuable model system in the
study of Maf and its interacting factors in normal and abnormal
lens and anterior segment development.
RESULTS
Ofl mice
The original mutant animal was found amongst offspring in a
mutagenesis experiment at the Institute of Mammalian
Genetics, Neuherberg. Males of genotype (C3H/HeEl 102/
El)F1 were irradiated with a dose of 1.5 Gy X-rays and mated at
such an interval afterwards that treated spermatogonial stem
cells were sampled (11). The mutant animal, J-361, had an
‘opaque flecks in the lens’ phenotype, from which was derived
the symbol Ofl.
When the animal was mated to homozygous wild-type,
offspring with a similar pulverulent cataract phenotype were
produced (Fig. 1A). To test Mendelian segregation further
animals were crossed with strains C3H/HeH and 102/ElH
(Table 1).
In the cross with C3H/HeH, there was 1:1 segregation
(w2¼ 0.0098; P> 0.90), indicating complete penetrance and
normal viability. No marked variation in expression was
observed.
Among the offspring of crosses with 102/ElH, there was a
shortage of affected animals (w2¼ 7.76; P< 0.01). Some of
those scored as affected had an atypical phenotype. The pupil
was only partly dilated and the lens misshapen. Without
atropine the pupil was of normal size. Of 202 affected animals
25 (12.4%) were of this type, and of the 19 pairs of parents that
produced at least 10 young, 11 produced at least one atypical
animal.
Thus, the 102/ElH genetic background appears to affect both
penetrance and expressivity of the Ofl mutation. Forty mice of
strain 102/ElH were examined and no eye abnormalities were
detected, excluding the possibility that this atypical cataract
was not due to the Ofl gene but to a new cataract segregating in
the 102/ElH substrain. Two atypical animals crossed with 102/
ElH produced both typical and atypical Ofl young.
Figure 1. Eye defects in mouse and human Maf/MAF heterozygotes. (A)
Lenses of normal (left) and Maf Ofl/þ (right) mice showing pulverulent cataract
in Maf Ofl/þ. (B) Eye of human MAF heterozygote showing pulverulent catar-
act. For a full clinical presentation of the human patients see (4).
Table 1. Results of breeding from Ofl /þ heterozygotes
Parents Offspring
Small eyes
Cataract Normal Unfed Lived
Ofl/þþ/þ(C3H/HeH) 204 206 — —
Ofl/þþ/þ(102/ElH) 202a 262 — —
Ofl/þOfl/þ 205 119 34 15
Maf /þOfl/þ 74b 1 12
aTwenty-five were of atypical appearance.
bThese mice were not scored for cataract.
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Genetic mapping of Ofl
Mapping with visible markers assigned the Ofl locus to
chromosome(Chr) 8, between the markers Os and Mc1rE-so
with recombination Os (30.1 4.7)Ofl (11.8 3.4)Mc1rE-so
(data not shown). For refined mapping, offspring of an
interspecific backcross with Mus spretus were scored for
cataract and for Chr 8 microsatellite markers. Among 159
offspring the results were D8Mit242 (7/159)D8Mit115
(10/159)Ofl (5/159)D8Mit55, giving recombination percen-
tages D8Mit242 (4.40 1.63)D8Mit115 (6.29 1.93)Ofl
(3.14 1.38)D8Mit55. The Ofl locus was thus placed at
position ca. 60 cM on the consensus map, a region which
contains the locus of the transcription factor Maf.
Preparation of homozygotes
Among intercrosses of Ofl /þOfl /þ intended to produce
animals homozygous for Ofl, some females were dissected
when 14.5–16.5 days pregnant and others were allowed to go to
term. Among the young studied as fetuses there were some with
small eyes (Fig. 2D and Table 2). The ratio of normal to small-
eyed fetuses showed agreement with the 3:1 ratio expected if the
abnormal fetuses were homozygotes (w2¼ 0.25; 0.5<P< 0.7).
Sectioning revealed failure of differentiation of the lens fibres,
which remained in the state of columnar epithelium (Fig. 2E
and F). This was very similar to that described for homozygous
Maf null fetuses.
Among litters allowed to go to term there were again animals
with visibly small eyes, specifically small pupils. Externally they
appeared otherwise normal, with a normal colour and level of
activity. However, the majority failed to feed and died or
disappeared within 24 h. The remainder survived to at least 2
weeks of age, when they appeared small and with a tremor
(Fig. 2A). The lenses remained undifferentiated (Fig. 2C). These
small animals died at various ages over the following few weeks.
Statistical tests of agreement with an expected 3:1 ratio of
normal to small-eyed showed a significant shortage of the
presumed homozygotes. There were 49/373 homozygotes
(13.4%) giving a test for goodness of fit to a 3:1
segregation ratio of w2¼ 28.0; P< 0.001. Among the animals
with normal eyes at birth and later scored for cataract, there was
a good fit to a 2:1 ratio of 205 Ofl: 119 normal (w2¼ 1.68;
0.1<P< 0.2). A total of 12 Ofl mice from these intercrosses
were tested for homozygosity by breeding, and all bred as
heterozygotes. Thus, there is no evidence that the shortage of
homozygotes was the result of misclassification due to overlap
with the heterozygous phenotype. The shortage of homo-
zygotes could be explained in part at least by death of those
that failed to feed before discovery of the litter.
To test the candidacy of Maf as the underlying gene for Ofl,
two Maf þ/Maf  heterozygous females were crossed with
Ofl/þ males, and dissected when 15.5 days pregnant. Out of 23
fetuses, four showed typical small eyes on external inspection
(Fig. 2D and Table 2), in good agreement with a 3:1 ratio of
normal to affected (w2¼ 0.71; 0.3<P< 0.5). Histological
sections of small-eyed fetuses confirmed failure of differentia-
tion of lens fibres as seen in Maf /Maf  and Ofl/Ofl (Fig. 2G).
In addition, some crosses of Ofl/þ with Maf þ/Maf  were
allowed to go to term and out of 87 young 13 showed a
syndrome similar to that seen in both Maf /Maf  and Ofl/Ofl
homozygotes. This was taken as clear evidence that Ofl is
allelic with Maf.
Extraocular manifestations of Ofl homozygotes
The syndrome of small eyes, failure to feed, and small size and
tremor at weaning age resembles closely the description of
post-natal homozygous Maf null animals (5,9,10). In an
attempt to find causes for the small size and premature death,
three Maf /Ofl animals were killed and dissected when 105–
117 days old. The post mortem revealed kidneys which were
grossly abnormal to the naked eye, pale in colour and with a
lumpy surface. Histological sections showed marked tubular
nephritis with dilated tubules containing eosinophil casts in
some cases (Fig. 2I and J). Other organs appeared histologi-
cally normal.
To investigate this abnormality further, urine of Ofl/Ofl and
Maf /Ofl mice was tested with reagent strips (Combur Test,
Roche Diagnostics, UK), and more histological sections were
studied. Urine of affected animals tested positive for glucose
from about 4 weeks of age and progressed from 50 mg/100 ml
at 4 weeks to 300 or 1000 mg/100 ml at around 7–8 weeks.
Tests of blood glucose and plasma insulin levels were in the
normal range; hence the urinary abnormality was regarded as
of renal origin. Some Ofl/Ofl animals were killed at ages
ranging from 17 to 46 days, and Maf /Ofl at 50–57 days. In
two mice aged 17 and 20 days no kidney abnormality was
observed, but in two mice aged 26 and 30 days patches of
dilated tubules were visible. At ages of 46, 50 and 57 days
patches of dilated tubules were again visible, some with
eosinophil casts. The degree of severity varied among the
animals, the kidneys of the 50-day-old mouse being as severely
affected as those of the 117-day-old animal. Few animals were
available for study because of the early deaths of both Ofl/Ofl
and Maf /Ofl, but on the evidence available the abnormalities
in the two genotypes were similar.
Ofl/þ phenotype
On first examination of the eyes of Ofl /þ at 4–6 weeks of age
pulverulent cataracts were present (Fig. 1A). These were
similar in appearance to the pulverulent cataracts seen in
humans with an R288P MAF mutation (Fig. 1B) and a MAF
16q translocation (4). In Ofl /þ mice on a 102/ElH background,
in some cases the pupils, which were of normal size without
atropine, failed to dilate fully after atropine, suggesting some
aberration in development of the anterior segment which was
also seen in some human patients with MAF abnormality.
Nature of the Maf mutation in Ofl
Maf mRNA exists in a single-exon form which encodes a 370
amino acid polypeptide. The coding region was screened for
mutation using single-strand conformational polymorphism/
heteroduplex analysis on genomic DNA from homozygous,
heterozygous and control animals on the C3H/HeE1 and 102/E1
backgrounds. Band abnormality was detected in homozygotes
and heterozygotes in a fragment coding for part of the DNA-
binding region. Sequencing revealed a G to A transition at
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Figure 2. Phenotypes of Maf Ofl homozygotes and Maf  /Maf Ofl double heterozygotes. (A) Maf Ofl/Maf Ofl mouse with normal sib aged one month, showing small
size and closd eyes. (B and C) Sections of eyes of Maf Ofl/þ or þ/þ (B) and Maf Ofl/Maf Ofl (C) showing rudimentary lens in C. (D) Heads of normal (left) and
Maf /Maf Ofl fetuses aged 15.5 days showing visibly small eye in Maf /Maf Ofl. (E–G) Eyes of 15.5 day fetuses showing failure of lens differentiation (E)
Normal; (F) Maf Ofl/Maf Ofl; (G) Maf /Maf Ofl. (H–J) Kidneys of Maf Ofl/þ aged 73 days with normal kidney (H), Maf Ofl/Maf Ofl aged 46 days (I) and
Maf /Maf Ofl aged 50 days (J). (I) and (J) both show dilated tubules, some with eosinophil casts (arrows).
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nucleotide position 1803 of Maf (GenBank accession no.
S74567; Fig. 3A). This mutation substitutes an invariant
arginine to glutamine at amino acid position 291 (R291Q) in
the basic region DNA-binding domain of Maf (Fig. 3B). This
change was not present in the C3H/HeEl nor 102/El control
lines. There was no further Maf coding sequence abnormality.
Electromobility shift assays (EMSAs)
EMSAs have been used previously to demonstrate that the
MAF protein forms DNA–protein complexes with consensus
and variant TRE and CRE like MAREs (7). The TNT Coupled
Wheat Germ Extract System (Promega) was used in transcrip-
tion/translation reactions to generate peptides containing the
DNA-binding and leucine zipper domains of the R291Q mutant
and control proteins. Translation products were analysed after
labelling with [35S]methionine (Fig. 4A). EMSAs revealed
binding of the wild-type peptide to various oligonucleotides as
previously reported (Figs 4B and 5 and Table 3). Specificity of
binding was demonstrated by the addition of the unlabelled
Table 2. Dissections of pregnant females
Parents Number
of
females
Total
implantation
Normal Small
eyes
Moles Other
Ofl/þOfl/þ 14 133 78 29 22 4
Maf/þOfl/þ 2 24 19 4 — 1
Moles¼ remains of fetuses dying soon after implantation.
Other¼ four dead at ca. 10 days, one doubtful for small eyes.
Figure 3. Maf sequence in Ofl/þ and Ofl/Ofl mice and location of Maf/MAF mutations in the DNA-binding domain of the protein. (A) Direct sequencing of PCR
product from Ofl/þ, Ofl/Ofl and control mice. (i) Ofl/þ, heterozygous mutation, a G to A transition at nucleotide 1803 of Maf mRNA (GenBank accession no.
S74567), which results in an arginine to glutamine substitution at amino acid 291 of the protein product. (ii) Ofl/Ofl, homozygous mutation at nucleotide
1803. (iii) Control sequence. (B) The DNA-binding domain of MAF contains an extended homology region (EHR) and a basic region (BR). There is strong amino
acid sequence conservation in the DNA-binding domain amongst the large Maf proteins and across species (4). Arginine 291 of the mouse Maf protein is conserved
in all known large Maf proteins and lies six residues C terminal to the mutated arginine in the R288P human MAF mutation family when the conserved regions are
compared. (In all cases an asterisk indicates the position of the mutation.)
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oligonucleotide in each case, which successfully competed and
abolished the visible MAF–MARE complex, whereas unla-
belled non-specific competitor did not (Fig. 5). The mutant,
with glutamine substituted for arginine (R291Q), showed
variability in binding with absence of binding with 4/6
oligonucleotides tested (oligonucleotides 3, 4, 5 and 6; Fig. 5
and Table 3) compared with the normal protein. The MAF
proteins showed concentration-dependent binding to the
oligonucleotides (Fig. 4B); Furthermore, for the oligonucleo-
tides to which it bound, the mutant Maf protein demonstrated
competition with the wild-type protein (Fig. 4C). The 13 bp
TRE-type MARE contains the cis element TRE (TGACTCA),
while the 14 bp CRE-type MARE contains the CRE element
(TGACGTCA) in the middle. Absence of binding with the
R291Q mutant was seen when there was variation in these core
binding sequences with or without the presence of variation in
the 3 bp extended elements either side. The R291Q mutation
impairs DNA-binding with certain MARE-like oligonucleo-
tides and the R291 residue may be particularly important for
core binding.
DISCUSSION
This work provides evidence that the Ofl /þ pulverulent
cataract mutant involves a mutation in the Maf transcription
factor. Mapping studies demonstrate that the Ofl locus lies
close to that of Maf. The eye defects in Ofl/Ofl homozygotes
strongly resemble those in Maf null homozygotes and Ofl /þ
Maf/þ crosses produced young with a similar phenotype,
indicating non-complementation. Mutation analysis revealed an
Figure 4. (A) In vitro translation of Maf protein and control EMSAs. R291Q mutant and wild-type Maf were translated in vitro in the presence of [35S]methionine
and analysed by SDS gel electrophoresis. Bands at 30, 10 and 2 kDa represent background from wheat germ extract. Arrow shows translated Maf polypeptide.
(B) Concentration-dependent binding of Maf proteins. An increasing amount of mutant (left) and wild-type (right) Maf was added to the labelled MARE oligo-
nucleotide (oligo 4) to demonstrate concentration-dependent binding. The protein–oligonucleotide complexes are arrowed. (C) Concentration-dependent competi-
tion of R291Q mutation with wild-type MAF for DNA binding. A reduction in the binding of the wild-type protein to oligonucleotide 1 in the presence of
increasing amounts of R291Q mutant MAF protein is demonstrated. The protein–oligonucleotide complexes are arrowed.
Table 3. Oligonucleotide sequences and binding to mutant and wild-type Maf
proteins
Oligonucleotidea Sequenceb Binding
Maf control Maf R291Q
1 (1) TGCTGACTCAGCA þ þ
2 (2) TGCTGACGTCAGCA þ þ
3 (3) TGCTGATTCAGCA þ 
4 (9) TGCCGACTCGGCA þ 
5 (28) TGCCGACGTCATCC þ 
6 (30) TGCCGACGTCATTG þ 
aBracketed number refers to previously assigned oligonucleotide number (7).
bNucleotide sequences of only the varied consensus elements of the
oligonucleotides are shown. Nucleotides matches with the MAREs are
underlined.
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Figure 5. (A) DNA-binding activity of in vitro translated R291Q mutant and wtMaf to MARE oligonucleotide 1 (see Table 3). Both the mutant and wild-type Maf
proteins bind to the consensus TRE core element. Immunoprecipitation to remove the translated, FLAG-tagged protein using ANTI-FLAG1 M2 Affinity Gel
reduced DNA binding [lanes 5 (R291Q) and 7 (wild-type Maf)]. The recovered, immunoprecipitated protein demonstrated normal DNA binding [lanes 6
(R291Q) and 8 (wild-type Maf)]. In vitro translation of a control luciferase template (lane 9) demonstrated no DNA binding. (B) DNA-binding activity of in vitro
translated R291Q mutant and wild-type Maf to further MARE oligonucleotides. Both the mutant and wild-type Maf proteins bind to the consensus element with a
CRE core (oligo 2) while variation in the core sequence (oligos 3 and 4) demonstrate loss of binding by the R291Q mutant protein but not the wild-type Maf
protein. Lane 1, negative control; lane 2, Maf protein; lane 3, additional specific competitor oligonucleotide; lane 4, additional non-specific competitor.
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R291Q substitution in the DNA-binding domain of the Maf
protein which is present in heterozygous form in Ofl /þ,
homozygous in Ofl/Ofl and absent in the parent line that
underwent mutagenesis. In view of the clear evidence that Ofl
involves a mutation in the Maf gene, the symbol should be
changed to Maf Ofl.
MAF gene involvement has been identified in two human
cataract families both with pulverulent cataract, one with a
translocation and the other with an R288P substitution in the
basic region of the DNA-binding domain close to the R291Q
mouse mutation (4). Maf Ofl also results in pulverulent cataract,
providing a valuable model of mammalian cataract.
In homozygotes for Maf Ofl and for the null alleles there are
additional non-ocular manifestations. The proportions of
Maf Ofl/Maf Ofl and Maf/Maf Ofl were normal at 14.5–16.5
days gestation. However, fewer than expected Maf Ofl/Maf Ofl
homozygotes were found at birth and, while externally
normal, the majority failed to feed and died. This has been
reported for the null alleles, and was also seen with Maf/
Maf Ofl animals. Kim et al. (9) reported death of null
homozygotes at 17.5–18.5 days gestation, but this has not
been studied in Maf Ofl/Maf Ofl. Maf Ofl/Maf Ofl and Maf /
Maf Ofl animals that fed and survived to 2 weeks of age were
small in size [also reported by Kim et al (9) in Maf null
homozygotes] and showed significant tremor. With the other
two knockouts, almost no homozygotes survived to weaning
age, suggesting that Maf Ofl/Maf Ofl and Maf /Maf Ofl animals
were less severely affected than the homozygous null animals.
However, there was some variation reported among the three
knockouts and it is not clear whether this apparently poorer
survival of the null homozygotes is a real effect, or depends
on genetic background or environmental conditions. Among
Maf Ofl/Maf Ofl and Maf /Maf Ofl homozygotes that survived
beyond one month a new effect, of tubular nephritis, was
found. The mechanism by which Maf mutation produces the
nephritis, the small size and the shaky behaviour is not known
although it is of note that Maf is expressed in kidney and
brain (5).
The R291Q substitution occurs in a conserved arginine
residue, the seventh in the basic region of the highly-conserved
DNA-binding domain of large Maf proteins (Fig. 3). It replaces
a basic positively charged polar residue with an electrically
neutral glutamine. Structural motif comparisons show that this
residue is the last amino acid of a sequence that resembles a
helix–turn–helix DNA-binding motif that may make direct
DNA contacts (12).
EMSA analysis of the R291Q protein reveals loss of DNA-
binding activity with a subset of MARE-like oligonucleotides,
confirming that R291 is a critical residue for DNA-binding.
Loss of binding (with oligonucleotide 4 in our study) had
previously been demonstrated when this residue was artificially
substituted with glutamate (7). DNA-binding of R291Q with
two MARE-like oligonucleotides was indistinguishable from
normal on gel shift assay. The 13 and 14 bp consensus binding
sequences of the MAREs contain core TRE and CRE elements
with extended recognition elements on both sides (7). In vitro
analysis reveals that none of the residues in the MAREs are
completely conserved (7) and lack of conservation is also a
feature of potential MAREs recognized in the promoters of a
variety of crystallin genes (10). Loss of binding was observed
when the core TRE or CRE element contained a mismatch with
or without extended element conservation (oligonucleotides 3,
4, 5 and 6). This implies that arginine 291 is critical for core
element binding and suggests that the mutant protein is likely
to exert a differential downstream effect amongst its binding
targets.
Comparison of lens phenotypes for Maf mutation suggests
that the Maf Ofl substitution mutation is dominant-negative in
its effect. The eye phenotype in homozygotes for the three
Maf knockouts closely resembles that in Maf Ofl/Maf Ofl
homozygotes. The lens vesicle forms normally and separates
from the overlying future cornea. The anterior lens epithelium
appears normal but lens fibre cells fail to differentiate and
remain as columnar epithelium. Heterozygotes for each of the
three null alleles reveal no specific ocular anomalies. This is
in contrast to the Maf Ofl heterozygote (Maf Ofl/þ), which
demonstrates a juvenile pulverulent cataract. This shows that,
as well as being important in lens fibre differentiation, Maf is
required for maintaining lens fibre clarity. Maf functions as a
dimer and is able to form homo- and heterodimers (13,14). In
the heterozygous form it is likely that the R291Q allele
interferes in a dominant-negative, or dominant-dysregulatory,
manner with dimer function since a phenotypic effect is seen,
i.e. cataract is present compared with the absence of a
phenotype where haploinsufficiency is present. This is similar
to the variability in phenotypes seen with dominant-negative
and haploinsufficiency mutations in Mitf, a basic helix–loop–
helix–leucine–zipper transcription factor which also functions
as a dimer (15).
It is recognized that marked genetic heterogeneity exists
amongst the causes of anterior segment and lens abnormal-
ities. Modifier effects with different strains have been
observed in other mouse anterior segment mutants (16,17).
It is likely that the phenotypic heterogeneity present in
humans in these conditions, including the MAF phenotype, is
also contributed to by different alleles of critical interacting
genes. Anterior segment abnormality (e.g. iris coloboma,
microcornea, Peters anomaly) was present in some of the
human patients with the MAF R288P mutation and MAF
translocation. When mouse Maf Ofl was crossed with C3H/
HeH the heterozygous mutant showed good penetrance and
constant expressivity, with pulverulent cataract and no other
anomalies. However, when crossed with 102/ElH there was a
shortage of affected animals, suggesting incomplete pene-
trance while the appearance of a new phenotype, with
irregularities of the pupil and lens, suggests that genetic
modifiers contributed to the ocular abnormalities produced by
the Maf Ofl mutation. This points to the importance of Maf
interacting factors in development of the anterior segment and
suggests that the Ofl mutant is a valuable model for the study
of the genetic factors underlying normal and abnormal lens
and anterior segment development.
MATERIALS AND METHODS
Mouse breeding
The mice described here were bred at Harwell in accordance
with guidelines issued by the Medical Research Council in
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‘Responsibility in the use of animals for medical research’
(July 1993) and under Home Office project licences 30/000875
and 30/1517. The stock was maintained by crossing Ofl /þ
mice either to inbred strain C3H/HeH or to strain 102/ElH.
Preliminary mapping was carried out by crosses with visible
marker genes. For more detailed mapping Ofl /þ female mice
were crossed with Mus spretus males and Ofl /þ offspring were
crossed to C3H/HeH to generate an interspecific backcross.
Offspring of this backcross were scored for cataract and for
polymorphisms of microsatellite markers located in the region
of interest indicated by the preliminary mapping, using DNA
prepared from the spleen.
The Maf knockout heterozygotes were provided by
Dr L. Glimcher.
Scoring for cataracts
Scoring for cataracts was carried out at the age of 4–6 weeks.
Dilation of the pupil was achieved with a drop of 1% atropine
sulfate (Schering-Plough Ltd, UK) applied at least 10 min
before examination. Eyes were examined at 20magnification
using a slit-lamp (Zeiss 30SL/M).
Histology
For fetuses and newborn animals whole heads were sectioned
whereas for older animals whole eyes were used. Material from
fetuses was fixed in Bouin’s fixative or 10% neutral formal-
saline and post-natal samples were fixed in formal-saline.
Samples were embedded in paraffin wax, sectioned and stained
with haematoxylin and eosin. For kidney histology material
was fixed in formal-saline.
Mutation analysis
Genomic DNA was extracted from murine Ofl heterozygotes,
homozygotes and control strains C3H/HeH and 102/ElH. PCR
amplification of the Maf gene was performed (primers on
request). DNA (40 ng) was suspended in a 20 ml reaction
containing 10 pmol of each forward and reverse primer,
0.75 mM dATP, dGTP, dCTP, dTTP, 67 mM Tris–HCl (pH
8.0), 3.7 mM MgCl2, 6.7 mM EDTA, 16 mM (NH4)2SO4
0.085 mg/ml BSA and 0.1 units of Taq DNA polymerase.
Owing to the GC sequence content of this gene, some reactions
required the addition of enhancing agents either DMSO at 10%
or both DMSO at 10% and Betaine at 1 M final concentration.
Samples were processed through 30 cycles of amplification
consisting of 45 s at 94C (denaturation), 45 s at 58C
(annealing) and 1 min at 72C (extension). The final step was
lengthened to 10 min. For SSCP/heteroduplex analysis, 1 vol of
PCR product was mixed with 1 vol of formamide loading dye
and denatured at 96C for 5 min prior to loading on a 8%
acrylamide/bis-acrylamide gel. Gels were run at 350 V over-
night at 4C and silver stained according to standard protocols.
Gels were inspected for abnormal bands. Direct sequencing of
PCR products were performed using the BigDyeTM Terminator
Cycle Sequencing Ready Reaction Kit (Applied Biosystems)
on a fluorescent sequencer (ABI 377) in accordance to the
manufacturer’s instructions.
Maf R291Q and control protein expression
On attempting to clone the Maf gene we found toxicity to
bacterial cells as reported by others (18). In an alternative
approach, primers were designed spanning the mutated DNA
sequence of interest including regions coding for the DNA-
binding domain and the leucine zipper. A T7 promoter/FLAG
tagged linker was attached to the forward primer for use of the
PCR product in subsequent downstream coupled transcription/
translation reactions. Primer pair sequences were as follows: 50-
GGA TCC TAA TAC GAC TCA CTA TAG GAA CAG ACC
ACC ATG GAT TAC AAG GAT GAC GAC GAC CGC TTC
TCG GAC GAG CAG TTG-30 and 50-GCG AGC TTG GCC
CTG CAA CTA GCA AG-30. PCR amplification was
performed from murine homozygous Ofl/Ofl and wild-type
DNA using the ReddyMix Hi-Fidelity Extensor Master Mix 1
PCR system (Abgene). Transcription/translation reactions were
performed using the TNT Coupled Wheat Germ Extract
System (Promega) in accordance with the manufacturer’s
guidelines. Typically 1 mg of template was used in reactions
and radiolabelled with [35S]methionine. Reactions were
incubated for up to 120 min at 30C. Translation reactions
were analysed using a 4% stacking polyacrylamide gel and a
12% separating gel run in Tris–glycine running buffer. A 5 ml
aliquot of the translation reaction was removed and mixed with
20 ml of SDS sample buffer, heated at 100C for 10 min prior to
loading the entire volume initially into the stacking gel
alongside a suitable marker (Invitrogen). Samples were subject
to electrophoresis through the stacking gel using a constant
current of 15 and 30 mA in the separating gel. Gels were run
for 3 h and then fixed in fixing solution (50% methanol, 10%
glacial acetic acid) for 30 min and further fixed for a further
5 min in 7% acetic acid, 7% methanol and 1% glycerol to
prevent the gel from cracking during drying. Gels were dried
for 90 min using a conventional gel dryer and exposed
overnight at 70C using Hyperfilm X-ray film.
Immunoprecipitation of FLAG-tagged proteins
FLAG-tagged fusion proteins were immunoprecipitated prior to
use in subsequent downstream EMSAs. Immunoprecipitations
were performed using the EzviewTMRed ANTI-FLAG M2
Affinity Gel in accordance with the manufacturer’s guidelines
(Sigma). Elution of the FLAG-fusion protein was performed
under native conditions by competition with the 3 FLAG
peptide in accordance to the manufacturer’s guidelines (Sigma).
For long-term storage eluted proteins were stored at 20C.
EMSAs
Transcription/translation products of comparable concentration
were used in EMSAs with [32P]labelled double-stranded
oligonucleotides. These included the consensus TRE-type
MARE (TGCTGACTCAGCA), the consensus CRE-type
MARE (TGCTGACGTCAGCA), as well as others with
various mismatches in their binding sequences (Table 3) as
described previously (7). Gel shift assays were performed using
the Gel Shift Assay System (Promega) in accordance with the
manufacturer’s instructions. The proteins were preincubated at
30C for 10 min in 1 Gel Shift Binding Buffer (Promega). For
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each oligonucleotide positive, negative, specific competitor and
random competitor reactions were set up. Competed reactions
were carried out using 100 pmol of the same, unlabelled cold
oligonucleotide. Non-specific competitor reactions were per-
formed using 0.5 mg/ml of PUC18 DNA. Following incubation
1 ml of 32P was added to each reaction. Incubation was
continued for a further 20 min at 30C. To each reaction 1 ml of
10 gel loading buffer (250 mM Tris–HCl pH 7.5, 0.2%
bromophenol blue, 40% glycerol) was added per reaction and
products were analysed on a pre-run 4% polyacrylamide gel in
0.5 TBE (filter-sterilized) for 10 min at 350 V. After loading
the samples, gels were run in 0.5 TBE at room temperature at
350 V until the bromophenol blue dye had run three-quarters of
the way down the gel, 45 min. Gels were transferred to a sheet
of Whatman 3 MM paper, covered with plastic wrap and dried
using a conventional gel dryer at 70C for 120 min. Gels were
exposed to X-ray film 1 h to overnight at 70C with an
intensifying screen. Autoradiograms were then inspected for
presence or absence of protein/oligonucleotide binding.
ACKNOWLEDGEMENTS
We thank M. Harrison and N. Chrobot for animal care,
T. Hacker and colleagues for histology, A. Ford and colleagues
for photography, L. Cobb for advice on kidney pathology, and
R. Cox for measurements of blood glucose and insulin. R.V.J. is
a Neil Hamilton Fairley Research Fellow (Reference 997006)
with the National Health and Medical Research Council of
Australia and also acknowledges a Paediatric Travelling
Fellowship from the Royal Australasian College of Physicians.
G.C.M.B. is a Wellcome Trust Senior Clinical Research Fellow.
R.P. is supported by the Birth Defects Foundation. This work is
also supported by the Birth Defects Foundation. F.L.M. is
supported by the Swiss National Science Foundation
(32-65250.01).
REFERENCES
1. Francis, P.J., Berry, V., Moore, A.T. and Bhattacharya, S. (1999) Lens
biology: development and human cataractogenesis. Trends Genet., 15,
191–196.
2. Hammond, C.J., Duncan, D.D., Snieder, H., de Lange, M., West, S.K.,
Spector, T.D. and Gilbert, C.E. (2001) The heritability of age-related
cortical cataract: the twin eye study. Invest. Ophthal. Visual Sci., 42,
601–605.
3. Favor, J. and Neuhauser-Klaus, A. (2000) Saturation mutagenesis for
dominant eye morphological defects in the mouse Mus musculus. Mamm.
Genome, 11, 520–525.
4. Jamieson, R.V., Perveen, R., Kerr, B., Carette, M., Yardley, J., Heon, E.,
Wirth, M.G., van Heyningen, V., Donnai, D., Munier, F. et al. (2002)
Domain disruption and mutation of the bZIP transcription factor, MAF,
associated with cataract, ocular anterior segment dysgenesis and
coloboma. Hum. Mol. Genet., 11, 33–42.
5. Kawauchi, S., Takahashi, S., Nakajima, O., Ogino, H., Morita, M.,
Nishizawa, M., Yasuda, K. and Yamamoto, M. (1999) Regulation of lens
fiber cell differentiation by transcription factor c-Maf. J. Biol. Chem.,
274, 19254–19260.
6. Ogino, H. and Yasuda, K. (2000) Sequential activation of transcription
factors in lens induction. Dev. Growth Differ., 42, 437–448.
7. Kataoka, K., Noda, M. and Nishizawa, M. (1994) Maf nuclear oncoprotein
recognizes sequences related to an AP-1 site and forms heterodimers with
both Fos and Jun. Mol. Cell Biol., 14, 700–712.
8. Kerppola, T.K. and Curran, T. (1994) A conserved region adjacent to the
basic domain is required for recognition of an extended DNA binding site
by Maf/Nrl family proteins. Oncogene, 9, 3149–3158.
9. Kim, J.I., Li, T., Ho, I.C., Grusby, M.J. and Glimcher, L.H. (1999)
Requirement for the c-Maf transcription factor in crystallin gene regulation
and lens development. Proc. Natl Acad. Sci. USA, 96, 3781–3785.
10. Ring, B.Z., Cordes, S.P., Overbeek, P.A. and Barsh, G.S. (2000) Regulation
of mouse lens fiber cell development and differentiation by the Maf gene.
Development, 127, 307–317.
11. Favor, J. (1989) Mammalian germ cell mutagenesis data and human genetic
risk. Biol. Zent. bl, 108, 309–321.
12. Dlakic, M., Grinberg, A.V., Leonard, D.A. and Kerppola, T.K. (2001) DNA
sequence-dependent folding determines the divergence in binding
specificities between Maf and other bZIP proteins. Embo J., 20, 828–840.
13. Kataoka, K., Noda, M. and Nishizawa, M. (1996) Transactivation activity
of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf
proteins. Oncogene, 12, 53–62.
14. Kerppola, T.K. and Curran, T. (1994) Maf and Nrl can bind to AP-1 sites
and form heterodimers with Fos and Jun. Oncogene, 9, 675–684.
15. Steingrimsson, E., Moore, K.J., Lamoreux, M.L., Ferre-D’Amare, A.R.,
Burley, S.K., Zimring, D.C., Skow, L.C., Hodgkinson, C.A., Arnheiter, H.,
Copeland, N.G. et al. (1994) Molecular basis of mouse microphthalmia
(mi) mutations helps explain their developmental and phenotypic
consequences. Nat. Genet., 8, 256–263.
16. Gould, D.B. and John, S.W. (2002) Anterior segment dysgenesis and the
developmental glaucomas are complex traits. Hum. Mol. Genet., 11,
1185–1193.
17. Smith, R.S., Zabaleta, A., Kume, T., Savinova, O.V., Kidson, S.H.,
Martin, J.E., Nishimura, D.Y., Alward, W.L., Hogan, B.L. and John, S.W.
(2000) Haploinsufficiency of the transcription factors FOXC1 and
FOXC2 results in aberrant ocular development. Hum. Mol. Genet., 9,
1021–1032.
18. Kataoka, K., Nishizawa, M. and Kawai, S. (1993) Structure-function
analysis of the maf oncogene product, a member of the b-Zip protein
family. J. Virol., 67, 2133–2141.
594 Human Molecular Genetics, 2003, Vol. 12, No. 6
